Carl Hay

2.5k total citations · 1 hit paper
22 papers, 1.9k citations indexed

About

Carl Hay is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Carl Hay has authored 22 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Physiology. Recurrent topics in Carl Hay's work include Adenosine and Purinergic Signaling (8 papers), Virus-based gene therapy research (6 papers) and RNA Interference and Gene Delivery (5 papers). Carl Hay is often cited by papers focused on Adenosine and Purinergic Signaling (8 papers), Virus-based gene therapy research (6 papers) and RNA Interference and Gene Delivery (5 papers). Carl Hay collaborates with scholars based in United States, Japan and Australia. Carl Hay's co-authors include Paul L. Hallenbeck, Ya‐Wen Chiang, Qing Lin, Yung‐Nien Chang, Martha C. Bohn, DL Choi-Lundberg, H. Mohajeri, Beverly L. Davidson, Laura M. Hales and Ling Xu and has published in prestigious journals such as Science, Psychological Bulletin and Blood.

In The Last Decade

Carl Hay

22 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

1997 523 citations DL Choi-Lundberg, Qing Lin et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl Hay United States	16	669	501	451	395	386	22	1.9k
Sarah Booth United Kingdom	18	937 1.4×	615 1.2×	221 0.5×	79 0.2×	150 0.4×	26	3.1k
Jifen Li United States	20	879 1.3×	224 0.4×	146 0.3×	99 0.3×	29 0.1×	31	2.4k
Nancy R. Cox United States	28	849 1.3×	90 0.2×	376 0.8×	207 0.5×	43 0.1×	76	2.1k
Mariana Puntel United States	26	779 1.2×	427 0.9×	644 1.4×	160 0.4×	12 0.0×	47	1.8k
Rafael J. Yáñez‐Muñoz United Kingdom	29	1.7k 2.6×	158 0.3×	895 2.0×	544 1.4×	12 0.0×	67	3.2k
Toshihiko Ezashi United States	36	2.7k 4.0×	238 0.5×	793 1.8×	159 0.4×	20 0.1×	81	4.2k
Hanna Damke United States	16	2.2k 3.2×	108 0.2×	201 0.4×	371 0.9×	148 0.4×	19	3.1k
Peter Schu Germany	23	2.7k 4.1×	424 0.8×	227 0.5×	205 0.5×	373 1.0×	52	4.1k
Douglas E. Brough United States	27	1.8k 2.7×	708 1.4×	1.6k 3.6×	104 0.3×	13 0.0×	72	3.7k
L E Mobraaten United States	15	713 1.1×	354 0.7×	491 1.1×	95 0.2×	45 0.1×	28	2.1k

Countries citing papers authored by Carl Hay

Since Specialization

Citations

This map shows the geographic impact of Carl Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Hay more than expected).

Fields of papers citing papers by Carl Hay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Hay. The network helps show where Carl Hay may publish in the future.

Co-authorship network of co-authors of Carl Hay

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Hay. A scholar is included among the top collaborators of Carl Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Hay. Carl Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borodovsky, Alexandra, Yanjun Wang, Minwei Ye, et al.. (2018). Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models. Cancer Research. 78(13_Supplement). 3751–3751. 8 indexed citations

Yang, Rui, Kristine Misund, Geir Slupphaug, et al.. (2018). Abstract LB-117: Role of ectoenzymes CD39 and CD73 in the immune response to multiple myeloma. Cancer Research. 78(13_Supplement). LB–117. 1 indexed citations

Vijayan, Dipti, Deborah S. Barkauskas, Kimberley Stannard, et al.. (2017). Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases. OncoImmunology. 6(5). e1312044–e1312044. 22 indexed citations

Borodovsky, Alexandra, Yanjun Wang, Minwei Ye, et al.. (2017). Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression. Cancer Research. 77(13_Supplement). 5580–5580. 19 indexed citations

Hay, Carl, Erin Sult, Qihui Huang, et al.. (2016). Targeting CD73 in the tumor microenvironment with MEDI9447. OncoImmunology. 5(8). e1208875–e1208875. 229 indexed citations

Young, Arabella, Shin Foong Ngiow, Deborah S. Barkauskas, et al.. (2016). Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses. Cancer Cell. 30(3). 391–403. 306 indexed citations

Sandercock, Alan M., Sandrine Guillard, Kris F. Sachsenmeier, et al.. (2015). Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling. Molecular Cancer. 14(1). 147–147. 35 indexed citations

Hay, Carl, Erin Sult, Qihui Huang, et al.. (2015). Abstract 285: MEDI9447: enhancing anti-tumor immunity by targeting CD73 In the tumor microenvironment. Cancer Research. 75(15_Supplement). 285–285. 10 indexed citations

Larson, Ryan, Heidi K. Jessup, Carl Hay, et al.. (2015). Preclinical Analyses Support Clinical Investigation of Combined PD-L1 Blockade and Anti-CD19 CAR T Cell Therapy for the Treatment of NHL. Blood. 126(23). 5430–5430. 3 indexed citations

10.

Dimasi, Nazzareno, Ryan Fleming, Carl Hay, et al.. (2015). Development of a Trispecific Antibody Designed to Simultaneously and Efficiently Target Three Different Antigens on Tumor Cells. Molecular Pharmaceutics. 12(9). 3490–3501. 17 indexed citations

11.

Guillard, Sandrine, Kris F. Sachsenmeier, Carl Hay, et al.. (2013). Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type. Molecular Cancer. 12(1). 11–11. 39 indexed citations

12.

Sachsenmeier, Kris F., Carl Hay, Lori Clarke, et al.. (2012). Development of a Novel Ectonucleotidase Assay Suitable for High-Throughput Screening. SLAS DISCOVERY. 17(7). 993–998. 15 indexed citations

13.

Hales, Laura M., et al.. (2008). Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus. Journal of General Virology. 89(5). 1265–1275. 295 indexed citations

14.

Reddy, P. Seshidhar, Kevin D. Burroughs, Laura M. Hales, et al.. (2007). Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers. JNCI Journal of the National Cancer Institute. 99(21). 1623–1633. 195 indexed citations

15.

Schepelmann, Silke, Paul L. Hallenbeck, Lesley Ogilvie, et al.. (2005). Systemic Gene-Directed Enzyme Prodrug Therapy of Hepatocellular Carcinoma Using a Targeted Adenovirus Armed with Carboxypeptidase G2. Cancer Research. 65(12). 5003–5008. 27 indexed citations

16.

Ryan, Patricia C., John Jakubczak, David A. Stewart, et al.. (2004). Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer. Cancer Gene Therapy. 11(8). 555–569. 36 indexed citations

17.

Jakubczak, John, Patricia C. Ryan, M Gorziglia, et al.. (2003). An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.. PubMed. 63(7). 1490–9. 83 indexed citations

18.

Hay, Carl, Héctor De León, John Jakubczak, et al.. (2001). Enhanced Gene Transfer to Rabbit Jugular Veins by an Adenovirus Containing a Cyclic RGD Motif in the HI Loop of the Fiber Knob. Journal of Vascular Research. 38(4). 315–323. 26 indexed citations

19.

Hay, Carl, et al.. (2001). Differential Cell Cycle Progression Patterns of Infiltrating Leukocytes and Resident Cells After Balloon Injury of the Rat Carotid Artery. Arteriosclerosis Thrombosis and Vascular Biology. 21(12). 1948–1954. 21 indexed citations

20.

Choi-Lundberg, DL, Qing Lin, Yung‐Nien Chang, et al.. (1997). Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy. Science. 275(5301). 838–841. 523 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact